BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31277480)

  • 1. The Unsolved Puzzle of c-Rel in B Cell Lymphoma.
    Kober-Hasslacher M; Schmidt-Supprian M
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The c-Rel transcription factor and B-cell proliferation: a deal with the devil.
    Gilmore TD; Kalaitzidis D; Liang MC; Starczynowski DT
    Oncogene; 2004 Mar; 23(13):2275-86. PubMed ID: 14755244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
    Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
    Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study.
    Faumont N; Taoui O; Collares D; Jais JP; Leroy K; Prévaud L; Jardin F; Molina TJ; Copie-Bergman C; Petit B; Gourin MP; Bordessoule D; Troutaud D; Baud V; Feuillard J
    Front Oncol; 2021; 11():638897. PubMed ID: 33959502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein.
    Weniger MA; Gesk S; Ehrlich S; Martin-Subero JI; Dyer MJ; Siebert R; Möller P; Barth TF
    Genes Chromosomes Cancer; 2007 Apr; 46(4):406-15. PubMed ID: 17243160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.
    Hu X; Baytak E; Li J; Akman B; Okay K; Hu G; Scuto A; Zhang W; Küçük C
    Leuk Res; 2017 Mar; 54():30-38. PubMed ID: 28095352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
    Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
    Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
    Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
    Martín-Subero JI; Gesk S; Harder L; Sonoki T; Tucker PW; Schlegelberger B; Grote W; Novo FJ; Calasanz MJ; Hansmann ML; Dyer MJ; Siebert R
    Blood; 2002 Feb; 99(4):1474-7. PubMed ID: 11830502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas.
    Rodig SJ; Savage KJ; Nguyen V; Pinkus GS; Shipp MA; Aster JC; Kutok JL
    Am J Surg Pathol; 2005 Feb; 29(2):196-203. PubMed ID: 15644776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells.
    Grumont RJ; Rourke IJ; O'Reilly LA; Strasser A; Miyake K; Sha W; Gerondakis S
    J Exp Med; 1998 Mar; 187(5):663-74. PubMed ID: 9480976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma.
    Goff LK; Neat MJ; Crawley CR; Jones L; Jones E; Lister TA; Gupta RK
    Br J Haematol; 2000 Nov; 111(2):618-25. PubMed ID: 11122110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma.
    Palanisamy N; Abou-Elella AA; Chaganti SR; Houldsworth J; Offit K; Louie DC; Terayu-Feldstein J; Cigudosa JC; Rao PH; Sanger WG; Weisenburger DD; Chaganti RS
    Genes Chromosomes Cancer; 2002 Feb; 33(2):114-22. PubMed ID: 11793437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of different NF-kappaB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling.
    Baltathakis I; Alcantara O; Boldt DH
    J Cell Biochem; 2001 Aug 1-9; 83(2):281-90. PubMed ID: 11573245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant rel/nfkb genes and activity in human cancer.
    Rayet B; Gélinas C
    Oncogene; 1999 Nov; 18(49):6938-47. PubMed ID: 10602468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma.
    Fukuhara N; Tagawa H; Kameoka Y; Kasugai Y; Karnan S; Kameoka J; Sasaki T; Morishima Y; Nakamura S; Seto M
    Cancer Sci; 2006 Jun; 97(6):499-504. PubMed ID: 16734728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors.
    Bash J; Zong WX; Banga S; Rivera A; Ballard DW; Ron Y; Gélinas C
    EMBO J; 1999 May; 18(10):2803-11. PubMed ID: 10329626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology of human lymphoid malignancies revealed by gene expression profiling.
    Staudt LM; Dave S
    Adv Immunol; 2005; 87():163-208. PubMed ID: 16102574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.